Day One Biopharmaceuticals Inc. (DAWN) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Day One Biopharmaceutical...

    NASDAQ: DAWN · Real-Time Price · USD
    7.35
    -0.12 (-1.61%)
    At close: Sep 09, 2025, 11:50 AM

    Day One Biopharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 124.97M 230.78M 85.26M 284.31M
    Short-Term Investments
    		 406.75M 135.56M 257.01M n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 121K 214K 469K 169K
    Receivables
    		 13.88M n/a n/a n/a
    Inventory
    		 3.32M n/a n/a n/a
    Other Current Assets
    		 4.37M 2.35M 1.01M 1.01M
    Total Current Assets
    		 562.33M 375.27M 347.87M 289.37M
    Property-Plant & Equipment
    		 4.71M 560K 719K 284K
    Goodwill & Intangibles
    		 15.63M n/a n/a n/a
    Total Long-Term Assets
    		 20.46M 774K 1.19M 453K
    Total Assets
    		 582.79M 376.05M 349.06M 289.82M
    Account Payables
    		 3.26M 2.58M 260K 1.74M
    Deferred Revenue
    		 1.55M n/a n/a 6.61M
    Short-Term Debt
    		 10K n/a 405K 204K
    Other Current Liabilities
    		 68.61M 1.04M 9.42M -100K
    Total Current Liabilities
    		 73.45M 29.51M 16.61M 8.66M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 761K n/a n/a n/a
    Total Long-Term Liabilities
    		 6.59M n/a 408K 16K
    Total Liabilities
    		 80.04M 29.51M 17.02M 8.67M
    Total Debt
    		 2.6M 408K 813K 220K
    Common Stock
    		 10K 9K 7K 6K
    Retained Earnings
    		 -554.08M -458.58M -269.67M -127.49M
    Comprehensive Income
    		 84K 9K -71K 0.00
    Shareholders Equity
    		 502.75M 346.54M -269.67M -127.49M
    Total Investments
    		 406.75M 135.56M 257.01M n/a

    Add to Watchlist